Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma

Class:Id	LiteratureReference:3645769
_displayName	A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma
_timestamp	2013-05-30 19:28:33
author	[Person:3645768] Tanaka, Shinji [Person:3645775] Mori, Masaki [Person:2023758] Mafune, K [Person:3645773] Ohno, Shinji [Person:3645774] Sugimachi, Keizo
created	[InstanceEdit:3645776] Orlic-Milacic, M, 2013-05-30
journal	Br. J. Cancer
pages	1557-60
pubMedIdentifier	10789724
title	A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma
volume	82
year	2000
(literatureReference)	[CandidateSet:3645765] TGFBR2 Kinase Domain Mutants [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:3645770] TGFBR2 E526Q [plasma membrane] [Homo sapiens] [FailedReaction:3645780] TGFBR2 KD mutants do not phosphorylate TGFBR1 [Homo sapiens] [Pathway:3645790] TGFBR2 Kinase Domain Mutants in Cancer [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma (3645769)